NewEdge Wealth LLC Has $15.46 Million Stock Position in Intuitive Surgical, Inc. $ISRG

NewEdge Wealth LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 21.6% in the 1st quarter, Holdings Channel.com reports. The fund owned 33,535 shares of the medical equipment provider’s stock after buying an additional 5,950 shares during the period. NewEdge Wealth LLC’s holdings in Intuitive Surgical were worth $15,459,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Wiregrass Investment Management LLC increased its stake in Intuitive Surgical by 5.3% in the 1st quarter. Wiregrass Investment Management LLC now owns 1,482 shares of the medical equipment provider’s stock valued at $683,000 after buying an additional 75 shares during the last quarter. First Citizens Bank & Trust Co. boosted its stake in shares of Intuitive Surgical by 0.6% during the 1st quarter. First Citizens Bank & Trust Co. now owns 20,944 shares of the medical equipment provider’s stock worth $9,655,000 after buying an additional 129 shares during the last quarter. First Trust Advisors LP boosted its stake in shares of Intuitive Surgical by 23.9% during the 1st quarter. First Trust Advisors LP now owns 166,438 shares of the medical equipment provider’s stock worth $76,726,000 after buying an additional 32,095 shares during the last quarter. Fortis Capital Management LLC grew its holdings in shares of Intuitive Surgical by 68.4% in the 1st quarter. Fortis Capital Management LLC now owns 628 shares of the medical equipment provider’s stock valued at $289,000 after acquiring an additional 255 shares in the last quarter. Finally, Temasek Holdings Private Ltd increased its position in shares of Intuitive Surgical by 416.4% in the first quarter. Temasek Holdings Private Ltd now owns 227,211 shares of the medical equipment provider’s stock valued at $104,742,000 after acquiring an additional 183,211 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on ISRG. Stifel Nicolaus dropped their target price on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a report on Friday, July 17th. Jefferies Financial Group decreased their price target on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research note on Wednesday, April 22nd. Raymond James Financial reaffirmed an “outperform” rating and set a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Citigroup dropped their price objective on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Finally, Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, June 13th. Twenty-one research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $523.46.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts still point to strong procedure growth, recurring revenue from instruments/services, a solid cash position, and new catalysts such as da Vinci 5, Ion lung biopsy, SP, and AI-driven software tools that could support long-term growth. Article title
• Positive Sentiment: Some commentary says margin gains, AI software expansion, and global growth could help Intuitive Surgical maintain its premium valuation despite slower U.S. procedure growth. Article title
• Positive Sentiment: One analysis argued the stock may already be pricing in a slowdown, noting ISRG’s growth rate has recently exceeded what is implied by its valuation, which could appeal to long-term investors. Article title
• Neutral Sentiment: Several recent articles frame the stock as a “strong business, but higher-risk valuation” story, with the company still growing but facing margin pressure from tariffs, product mix shifts, and softer demand in some areas. Article title
• Neutral Sentiment: Intuitive Surgical’s latest earnings were described as impressive, which helps support the bull case, but the market has already shifted to debating whether the stock can sustain its premium after the report. Article title
• Negative Sentiment: Analysts have trimmed fair value estimates and price targets, citing a reset in expectations tied to slower procedure growth, Affordable Care Act-related volume uncertainty, and lower MedTech valuation multiples. Article title
• Negative Sentiment: Competitive pressure is also building after Johnson & Johnson received U.S. authorization for its robotic surgery device, adding another rival in a market long dominated by ISRG’s da Vinci system. Article title
• Negative Sentiment: Multiple reports note the stock has fallen sharply this year and recently hit a new 1-year low after an analyst downgrade, underscoring continued investor concern over valuation and near-term growth. Article title

Insider Activity

In other news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the completion of the sale, the executive vice president directly owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the transaction, the director owned 120 shares of the company’s stock, valued at $55,620. This represents a 49.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 7,169 shares of company stock valued at $3,059,135 over the last three months. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $340.69 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $340.61 and a 52-week high of $603.88. The stock has a market cap of $120.66 billion, a price-to-earnings ratio of 39.03, a PEG ratio of 2.54 and a beta of 1.46. The firm’s 50-day moving average is $410.47 and its 200-day moving average is $462.47.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to analysts’ expectations of $2.83 billion. Intuitive Surgical had a return on equity of 17.09% and a net margin of 28.45%.Intuitive Surgical’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company posted $1.81 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 8.84 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.